Keysight Technologies Inc. has been a subject of several recent financial announcements. Investment firms such as Reinhart Partners, Rhumbline Advisers, Squarepoint Ops, Wellington Management Group, and GAMMA Investing LLC changed their stake in Keysight shares, with most increasing their positions except for First Hawaiian Bank. It’s highlighted that CEO and other insiders sold some of their shares.
Keysight's acquisition of Spirent has experienced legal challenges, with the Department of Justice requiring divestiture of some assets for antitrust reasons, this was later negotiated with VIAVI. Keysight has revealed its Q2 FY25 earnings, suggesting a favourable performance with JP Morgan subsequently raising the price target. Several advancements have taken place including launching advanced AI tool for RF chip design and a new high-speed oscilloscope. They have also worked with Synopsys, NIO and helped run a quantum computer with 256 Qubits. However, Keysight needs to divest some assets to complete the Spirent deal. The outcome of this deal can greatly impact Keysight’s future standing in the biotech market.
Keysight Technologies KEYS News Analytics from Tue, 04 Feb 2025 08:00:00 GMT to Sat, 07 Jun 2025 15:50:42 GMT - Rating 5 - Innovation 7 - Information 6 - Rumor -2
